Come up with a name for your new list and we'll add to it:
Vermillion raised a round of funding on May 20, 2015. Investors include
Cancer Prevention and Research Institute of Texas.
Vermillion, formerly Ciphergen Biosystems, is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcom…